SCHEMBL6821145

SCHEMBL6821145

CCNC(=O)Nc1cc(Br)ccc1Nc1ccc(C(=O)c2ccccc2C)c(OCC)c1

nearest known ligand 0.60

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPK13 O15264 10/20 0.60
MAPK12 P53778 10/20 0.60
MAPK11 Q15759 10/20 0.60
MAPK14 Q16539 10/20 0.60
SMN1; SMN2 Q16637 1/20 0.46
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
GAA P10253 1/20 0.39
MAPT P10636 2/20 0.38
LMNA P02545 1/20 0.38
HTT P42858 1/20 0.38
RAB9A P51151 2/20 0.37
PTPN2 P17706 1/20 0.37
PTPN1 P18031 1/20 0.37
PTPN6 P29350 1/20 0.37
NPC1 O15118 1/20 0.37
TDP1 Q9NUW8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6904569 0.91 MAPK13 (0.52) MAPK13MAPK12MAPK11MAPK14SMN1; SMN2
SCHEMBL6911630 0.86 MAPK13 (0.48) MAPK13MAPK12MAPK11MAPK14SMN1; SMN2
SCHEMBL6824376 0.86 MAPK14 (0.81) MAPK13MAPK12MAPK11MAPK14GAA
SCHEMBL6821115 0.86 MAPK13 (0.63) MAPK13MAPK12MAPK11MAPK14SMN1; SMN2
SCHEMBL6817801 0.86 MAPK1 (0.48) MAPK13MAPK12MAPK11MAPK14SMN1; SMN2
SCHEMBL6817802 0.86 MAPK1 (0.48) MAPK13MAPK12MAPK11MAPK14SMN1; SMN2
SCHEMBL6396132 0.84 MAPK14 (0.70) MAPK13MAPK12MAPK11MAPK14SMN1; SMN2
SCHEMBL6395887 0.83 MAPK13 (0.51) MAPK13MAPK12MAPK11MAPK14SMN1; SMN2
SCHEMBL6821134 0.82 MAPK13 (0.61) MAPK13MAPK12MAPK11MAPK14MEN1
SCHEMBL7195744 0.81 MAPK13 (0.56) MAPK13MAPK12MAPK11MAPK14SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1210325-B1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1BETA AND TNF-ALPHA LEO PHARMA AS (DK) 2004-10-06 EP disclosed
US-6750253-B1 INHIBITION OR DOWN REGULATION OF THE CYTOKINES IS POSSIBLY DUE TO AN INHIBITION OF MAP KINASES LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2004-06-15 US disclosed
EP-1210325-A1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1BETA AND TNF-ALPHA LEO PHARMACEUTICAL PRODUCTS LTD. A/S (LOVENS KEMISKE FABRIK PRODUKTIONSAKTIESELSKAB) (DK) 2002-06-05 EP disclosed
WO-2001005751-A1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) Leo Pharmaceutical Products Ltd. A/S (Løvens Kemiske Fabrik Produktionsaktieselskab) (DK) 2001-01-25 WO disclosed